ID : 1001
Type : Constrained Content : TEXT Mandatory : Yes Multiple values : No Unique : No |
Description : Centre ConticaBase
|
Possible values :
MEDIPATH Toulouse, Cabinet de Reims, Centre Patho de Metz, Cabinet de Douai, Cabinet d’Amiens, IHP Nantes, Centre Patho Dijon, Cabinet de la Roquette, Cabinet Mathurin, Lyon CLB, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Cabinet de Rennes, Villejuif IGR, Milan INT, Padova UNIPD, KLEUVEN, CHRU Lille, Saint-Louis, Bergonié, Curie, Mannheim, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Lausanne, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, Bruxelles, CJP, Paris Henri Mondor, Warsaw Cancer Center, Timone, Cochin, Rennes CEM, Heidelberg, Bonn, Tübingen, Haut-Lévèque Bordeaux, LUMC, Ambroise Paré APHP, Nantes CHU, Tours Trousseau, CPS Strasbourg, CHRU Montpellier, Limoges Dupuytren, Rouen CHB, Lyon IHOP, St Etienne ICLN-CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Bicêtre, Pitié Salpétrière, GHSN - LYON, Hôp. Civil Strasbourg, CHRU Caen, CHRU Brest, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, Centre Hospitalier - Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon) |
ID : 139
Type : Free value Content : TEXT Mandatory : Yes Multiple values : No Unique : Yes |
Description : The unique file number the patient has in his centre
|
|
ID : 140
Type : Free value Content : DATE Mandatory : Yes Multiple values : No Unique : No |
Description : The patient's birth date
|
|
ID : 141
Type : Constrained Content : TEXT Mandatory : Yes Multiple values : No Unique : No |
Description : The patient's gender
|
Possible values :
Female, Male |
ID : 181
Type : Free value Content : DATE Mandatory : Yes Multiple values : No Unique : No |
Description : The date when the patient has been created in the database
|
|
ID : 1
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour
|
Possible values :
No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family |
ID : 1018
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1080
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Has the patient another cancer
|
Possible values :
Yes, No, Unknown |
ID : 76
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date of the last follow up evaluation or date of death
|
|
ID : 1078
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Lost of follow-up
|
Possible values :
No, Yes |
ID : 1075
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Vital status at last contact
|
Possible values :
Alive, Dead |
ID : 1077
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Cause of death
|
Possible values :
- Dead of this cancer - Primary cancer - Metastatic disease - Dead of other cancer - Dead of treatment complication - Dead of other cause - Unknown |
ID : 1086
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1155
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1156
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1091
Type : Constrained Content : TEXT Mandatory : Yes Multiple values : No Unique : No |
Description : point de départ du développement de la tumeur |
Possible values :
Soft tissue, Viscera, Bone |
ID : 2
Type : Constrained Content : TEXT Mandatory : Yes Multiple values : No Unique : No |
Description : Site of tumour according to the scroll menu
|
Possible values :
- Soft tissue - Head and neck - Superficial areas of head - Sinus and nasal fossa - Deep facial areas - Orbit - Anterior skull base - Ear - lateral skull base and nasoharynx - Oral cavity - oropharynx - Larynx - trachea - Visceral space of the neck - Neck NOS - Other - Trunk wall - Chest wall - Axilla - Abdominal wall - Trunk - paraspinal - Buttock - Groin - Internal trunk - Retroperitoneum - Peritoneum - Pelvis - Thorax internal - Large vessels - Paratesticular - Lower limb - Thigh - Knee - Leg - Ankle - Foot - Toe - Upper limb - Shoulder girdle - Upper arm - Elbow - Forearm - Wrist - Hand - Finger - Viscera - Gastro Intestinal tractus - Oesophagus - Stomach - Duodenum - Appendix - Small intestine - Colon - Rectum - Anus - Gyneacological area - Uterus - Ovary - Fallopian tube - Vagina - Vulva - Others - Breast - Lung - Heart - Pleura - Thymus - Thyroid - Kidney - Bladder - Ureter - Prostate - Testis - Epididymis - Penis - Spleen - Liver - Pancreas - Gallbladder - Salivary gland - Tonsil - Adrenal - Brain - Meninges - Lymph node - Bone - Skull and face bone - Skull NOS - Ethmoid - Superior maxilla - Mandible - Bone face - Upper airways - Larynx - Bronchus - Nasal septum - Spine - Cervical spine - Dorsal spine - Lumbar spine - Basin, sacrum, coccyx - Basin - Sacrum - Coccyx - Hip joint - Other thoracic bone - Rib - Sternum - Clavicle - Superior limb and shoulder - Bone shoulder girdle - Scapula - Shoulder joint - Humerus - Elbow joint - Ulna - Radius - Wirst joint - Hand bone NOS - Carpal (Hand) - Metacarpals (Hand) - Hand phalanges - Hand joint - Inferior limb - Femur - Patella - Knee joint - Tibia - Fibula - Ankle joint - Bone foot NOS - Tarsals (Foot) - Metatarsals (Foot) - Foot phalanges - Foot joint |
ID : 193
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Laterality of bone tumour in human body
|
Possible values :
Left, Right, Median, Unspecified, Not applicable |
ID : 80
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Largest diameter of the tumour expressed in mm
|
|
ID : 3
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
|
Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary |
ID : 9
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)
|
Possible values :
- Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma |
ID : 143
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date of the first sampling which allowed the diagnosis of the current tumour
|
|
ID : 145
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1135
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath. Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes. Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No. |
Possible values :
No, Yes |
ID : 1136
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Quel était le diagnostic avant que le redressement de diag ? |
Possible values :
- Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of uncertain malignant potential (STUMP) - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma |
ID : 1137
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic. |
|
ID : 10
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8
|
Possible values :
1, 2, 3, NA |
ID : 1241
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1127
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Risque de malignité des GIST selon Miettinen
|
Possible values :
Very low risk, Low risk, Intermediate risk, High risk, NA |
ID : 1002
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : tumour developed in a previously irradiated area
|
Possible values :
No, Yes |
ID : 1004
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : tumour developed in a region with a preexisting lymphoedema
|
Possible values :
No, Yes |
ID : 150
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description : Tumour invasion of healthy adjacent tissues (NB: a deep intramuscular tumour systematically invades the adjacent muscle)
|
Possible values :
No, Dermis, Hypodermis, Vasculo-nervous, Bone, Muscle, Adjacent organ |
ID : 151
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules
|
Possible values :
No, Yes |
ID : 5
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes when there is a locoregional lymph node involvement detected by clinical and/or imaging evaluation
|
Possible values :
No, Yes |
ID : 6
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation
|
Possible values :
Yes, No, Skip |
ID : 1167
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
First event, Relapse |
ID : 1168
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1006
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
|
Possible values :
0, 1, 2, 3, 4, NA |
ID : 1076
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Cancer status at last contact
|
Possible values :
No evidence of this cancer, Evidence of this cancer, Unknown, Not Applicable |
ID : 1169
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available |
ID : 1170
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1153
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes, Curettage |
ID : 1079
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date of surgery
|
|
ID : 11
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
First, Second, Third |
ID : 12
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)
|
Possible values :
Excision, Wide resection, Compartimentectomy, Amputation |
ID : 1096
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Chirurgien qui a opéré la tumeur primaire Les chirurgiens Sarcome sont listés dans Network. Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network. |
|
ID : 1100
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute. |
Possible values :
No, Yes, Curettage |
ID : 1101
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Chirurgien qui a ré-opéré la tumeur primaire Les chirurgiens sarcome sont listés dans Network. Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network. |
|
ID : 112
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Expert pathologist observed if the tumour was spilt
|
Possible values :
Yes, No |
ID : 13
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)
|
Possible values :
R0, R1, R2, Not evaluable |
ID : 1185
Type : Free value Content : PERCENTAGE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1186
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Prosthesis, Autograft, Biomaterials |
ID : 1187
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Henderson 1, Henderson 2, Henderson 3, Henderson 4 |
ID : 201
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Isolated limb perfusion
|
Possible values :
No, Yes |
ID : 1171
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1191
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1178
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1179
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1184
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available |
ID : 14
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery
|
Possible values :
No, First, Second, Third, Palliative |
ID : 1172
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1173
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 158
Type : Free value Content : DECIMAL Mandatory : No Multiple values : No Unique : No |
Description : Total dose of radiotherapy given to the entity and expressed in Grays
|
|
ID : 1085
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: when the patient was treated by hormonotherapy
|
Possible values :
No, Yes |
ID : 1180
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1084
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: when the patient was treated by AINS
|
Possible values :
No, Yes |
ID : 1181
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1182
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
No, Radiofrequency, Cryotherapy, Embolisation, Other |
ID : 1005
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
|
Possible values :
No, Yes |
ID : 1029
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : no residual tumour at the primary site by clinical and imaging examinations
|
Possible values :
Yes, No, Not available |
ID : 16
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.
|
Possible values :
Yes, No |
ID : 198
Type : Free value Content : INTEGER Mandatory : Yes Multiple values : No Unique : No |
Description : Rank of local recurrence
|
|
ID : 74
Type : Free value Content : DATE Mandatory : Yes Multiple values : No Unique : No |
Description : Date of diagnosis of the first local recurrence
|
|
ID : 80
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Largest diameter of the tumour expressed in mm
|
|
ID : 3
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
|
Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary |
ID : 151
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules
|
Possible values :
No, Yes |
ID : 1002
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : tumour developed in a previously irradiated area
|
Possible values :
No, Yes |
ID : 1006
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
|
Possible values :
0, 1, 2, 3, 4, NA |
ID : 1170
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1153
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes, Curettage |
ID : 1079
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date of surgery
|
|
ID : 11
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
First, Second, Third |
ID : 12
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)
|
Possible values :
Excision, Wide resection, Compartimentectomy, Amputation |
ID : 1188
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Network, Outside Network |
ID : 1100
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute. |
Possible values :
No, Yes, Curettage |
ID : 1189
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Network, Outside Network |
ID : 112
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Expert pathologist observed if the tumour was spilt
|
Possible values :
Yes, No |
ID : 13
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)
|
Possible values :
R0, R1, R2, Not evaluable |
ID : 1185
Type : Free value Content : PERCENTAGE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1186
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Prosthesis, Autograft, Biomaterials |
ID : 1187
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Henderson 1, Henderson 2, Henderson 3, Henderson 4 |
ID : 1191
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1178
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1179
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1184
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available |
ID : 201
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Isolated limb perfusion
|
Possible values :
No, Yes |
ID : 1171
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 14
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery
|
Possible values :
No, First, Second, Third, Palliative |
ID : 1172
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1173
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 158
Type : Free value Content : DECIMAL Mandatory : No Multiple values : No Unique : No |
Description : Total dose of radiotherapy given to the entity and expressed in Grays
|
|
ID : 1085
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: when the patient was treated by hormonotherapy
|
Possible values :
No, Yes |
ID : 1180
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1084
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: when the patient was treated by AINS
|
Possible values :
No, Yes |
ID : 1181
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1005
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
|
Possible values :
No, Yes |
ID : 1182
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
No, Radiofrequency, Cryotherapy, Embolisation, Other |
ID : 1029
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : no residual tumour at the primary site by clinical and imaging examinations
|
Possible values :
Yes, No, Not available |
ID : 16
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.
|
Possible values :
Yes, No |
ID : 19
Type : Constrained Content : TEXT Mandatory : Yes Multiple values : Yes Unique : No |
Description : Location of first metastasis
|
Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other |
ID : 75
Type : Free value Content : DATE Mandatory : Yes Multiple values : No Unique : No |
Description : Date of diagnosis of the first metastasis
|
|
ID : 199
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Number of metastasic sites at diagnosis
|
|
ID : 209
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description : Location of further metastasis
|
Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other, No |
ID : 1190
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
No, Systemic treatment, Locoregional treatment, AINS, Other |
ID : 1007
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description : Choose one or several (CTRL + clic) type(s) of locoregional treatment for the treatment of metastasis
|
Possible values :
Surgery, Radiofrequency, Cryotherapy, Radiotherapy, Other |
ID : 1184
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available |
ID : 1005
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
|
Possible values :
No, Yes |
ID : 144
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : Yes |
Description : The sample reference in the center
|
|
ID : 146
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date on which the sample was removed
|
|
ID : 208
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Location of this metastasis sample (only for metastasis sample)
|
Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other |
ID : 23
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling
|
Possible values :
No, Systemic treatment, Radiotherapy, ILP, Other |
ID : 21
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Microbiopsy: sampling of the tumour with a core needleOpen biopsy: surgical resection of a piece of the tumour with a diagnostic intendTumour resection: surgical resection of the whole tumour
|
Possible values :
Microbiopsy, Open biopsy, Tumour resection, Curettage |
ID : 1160
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1161
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1162
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
In progress, Negative, Non interpretable, Positive |
ID : 1047
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Molecular Biology techniques performed
|
Possible values :
No, Yes |
ID : 1058
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
In progress, Negative, Positive, Non interpretable |
ID : 1129
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1361
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Fusion transcript gene 1
|
Possible values :
No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9 |
ID : 1360
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Fusion transcript unlisted gene 1
|
|
ID : 1362
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Fusion transcript gene 2
|
Possible values :
No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9 |
ID : 1363
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Fusion transcript unlisted gene 2
|
|
ID : 1158
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1159
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 1157
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 32
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Number of paraffin blocks with tumour available in your Centre
|
|
ID : 177
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: if sample of paraffin block is included in a TMA (Tissue Micro Array)
|
Possible values :
No, Yes |
ID : 178
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Centre where TMA is stored
|
Possible values :
ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University |
ID : 28
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: array-CGH done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1025
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Value of genomic index
|
Possible values :
GI1, GI2 |
ID : 1130
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1132
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 180
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : if the case has been reviewed using virtual slide
|
Possible values :
No, Yes |
ID : 24
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Storage temperature of the frozen material according to the scroll menu
|
Possible values :
-80°C, -140°C, Liquid nitrogen |
ID : 25
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Available: frozen material has not been used and is available in the local Center In use: frozen material is currently in use in one or several studies Terminated: there is no frozen material left but nucleic acids (DNA and/or RNA, 0) may be still available
|
Possible values :
Terminated, In use, Available |
ID : 79
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Number of tubes containing tumour fragments stored
|
|
ID : 27
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: karyotype showes a translocation
|
Possible values :
t(X;17)(p11;q25) (Alveolar soft part sarcoma), t(9;22)(q22;q12) (Extraskeletal myxoid chondrosarcoma), t(9;17)(q22;q11) (Extraskeletal myxoid chondrosarcoma), t(9;15)(q22;q21) (Extraskeletal myxoid chondrosarcoma), t(12;22)(q13;q12) (Clear cell sarcoma), t(11;22)(p13;q12) (Desmoplastic small round cell tumor), t(17;22)(q21;q13) (Dermatofibrosarcoma protuberans), t(11;22)(q24;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(21;22)(q22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(7;22)(p22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(17;22)(q12;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(2;22)(q33;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(1;16)(q21;q13) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(12;16)(q13;p11) (Liposarcoma, myxoid/round cell), t(12;22)(q13;q12) (Liposarcoma, myxoid/round cell), t(2;13)(q35;q14) (Alveolar rhabdomyosarcoma), t(1;13)(p36;q14) (Alveolar rhabdomyosarcoma), t(X;18)(p11;q11) (Synovial sarcoma) |
ID : 28
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: array-CGH done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1025
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Value of genomic index
|
Possible values :
GI1, GI2 |
ID : 29
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: expression profile done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1026
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Value of CINSARC
|
Possible values :
C1, C2 |
ID : 30
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: SNP analysis done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 31
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: miRNA analysis done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1130
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1132
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1131
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 26
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: karyotype done
|
Possible values :
Not done, Done |
ID : 189
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 78
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Total weigh of frozen tumours fragments in mg
|
|
ID : 1154
Type : Free value Content : TEXT Mandatory : Yes Multiple values : No Unique : Yes |
Description : The cell line reference in the center
|
|
ID : 1013
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Number of passages after put in culture of cells
|
Possible values :
-30, +30 |
ID : 1014
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Dilution done at each passage
|
Possible values :
1/2, 1/4, 1/8, 1/10 |
ID : 1015
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Number of days between 2 passages
|
|
ID : 1016
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Method to check cells are tumorous by chromosome spreading, FISH or sequencing
|
Possible values :
Yes, No, Not available |
ID : 28
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: array-CGH done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1025
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Value of genomic index
|
Possible values :
GI1, GI2 |
ID : 29
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: expression profile done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1026
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Value of CINSARC
|
Possible values :
C1, C2 |
ID : 31
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: miRNA analysis done
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 1017
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: multiFISH done
|
Possible values :
not done, done interpretable, not interpretable |
ID : 144
Type : Free value Content : TEXT Mandatory : Yes Multiple values : No Unique : Yes |
Description : The sample reference in the center
|
|
ID : 146
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date on which the sample was removed
|
|
ID : 23
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling
|
Possible values :
No, Systemic treatment, Radiotherapy, ILP, Other |
ID : 1027
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Type of material stored
|
Possible values :
Serum, Plasma, Lymphocytes, Total blood |
ID : 1028
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: consent obtained from the patient
|
Possible values :
Yes, No, NA |
ID : 178
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Centre where TMA is stored
|
Possible values :
ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University |
ID : 1131
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Not done, Done non interpretable, Done interpretable |
ID : 210
Type : Free value Content : INTEGER Mandatory : No Multiple values : No Unique : No |
Description : Rank of Chemotherapy line
|
|
ID : 1009
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date start of cycle of chemotherapy
|
|
ID : 1483
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1006
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
|
Possible values :
0, 1, 2, 3, 4, NA |
ID : 1010
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
90Y-Ibritumomab tiuxetan, Abraxane, Abemaciclib, ADEPT, AINS, Aldesleukin, Aldoxorubicin, Alectinib, Alemtuzumab, AMG 706, Amsacrine, Atezolizumab, Avapritinib, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Bezuclastinib/CGT9486, BI2536, Binimetinib, BKM120 - Buparlisib, Bleomycin, Bortezomib, Brostallicin, Busulfan, Cabazitaxel, Capecitabine, Carboplatin, Cabozantinib, Carmustine, Ceritinib, Cetuximab, Chlorambucil, Cisplatin, Cixutumumab, Cladribine, Clofarabine, Cobimetinib, Conatumumab, Crenigacestat, Crenolanib, Crisantaspase, Crizotinib, Cyclophosphamide, Cytarabine, Dabrafenib, Dacarbazine, Dactinomycin, Dalotuzumab, Dasatinib, Daunorubicin, DCC-2618, Deforolimus, Denosumab, Docetaxel, Dovitinib, Doxorubicin, Durvalumab, Emactuzumab, Encorafenib, Entrectinib, Epirubicin, Eribulin, Erlotinib, Etoposide, Everolimus, Evofosfamide, Farmorubicine, FDH, Fludarabine, Fluorouracil, Fotemustin, FPA0008, Fulvestrant, Gefitinib, Gemcitabine, Gemtuzumab, Gimatecan, Gliadel implants, Halichondrin B, HDM201, Hormonotherapy, Hydroxycarbamide, Idarubicin, IDRX-42, Ifosfamide, Imatinib, Interferon alpha, Interleukin-2, Iodine-131 tositumomab, Ipilimumab, Irinotecan, JX-594(Pexa-vec), Lapatinib, Larotrectinib, Lenalidomide, Lenvatinib, Leucovorin, Liposomal daunorubicin, Liposomal doxorubicin, Lomustine, Lornatinib, Masitinib, Melphalan, Mercaptopurine, Mesna, Methotrexate, Mitomycin, Mitotane, Mitoxantrone, Motesanib, NB003, NBTXR3, NGR-hTNF, Nilotinib, Nintedanib, Nivolumab, NVL-655, Olaparib, Olaratumab, Ombrabulin, Ontuxizumab (MORAb-004), Oxaliplatin, Paclitaxel, Palbociclib, Palifosfamide, Panitumumab, Panobinostat, Pazopanib, Pembrolizumab, Pemetrexed, Pentostatin, Pexidartinib, Placebo, Ponatinib, Prednisolone, Procarbazine, R1507 (Teprotumumab), Raltitrexed, Ramucirumab, Rasburicase, Regorafenib, Relatlimab, Ribociclib, Ridaforolimus, Ripretinib, Rituximab, RO5045337 / RG7112 (Nutlin), S9788, Satraplatin, Selpercatinib, Siremadlin (HDM201), Sirolimus, Sorafenib, Streptozocin, Sunitinib, Tamoxifen, Tasonermine, Tazemetostat, Tegafur-uracil, Temozolomide, Temsirolimus, Tenoposide, Thalidomide, Thiotepa, Tioguanine, Topotecan, Trabectedin, Trametinib, Trastuzumab, Tremelimumab, Treosulfan, Vinblastine, Vemurafenib, Vincristine, Vindesine, Vinorelbine, Vismodegib, Vistusertib, Warfarin, Other |
ID : 1005
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
|
Possible values :
No, Yes |
ID : 1019
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Clinical trial name according to the scroll menu
|
Possible values :
Clinical trial name to complete, 105SAR301 TAPPAS, 20140114, AB04030, AB07001, AB1010, AB11002, AcSé Crizotinib, ACSE Pembrolizumab, Acsé-eSMART-CSET, ADP-0044-002 - SPEARHEAD 1, ALDOXORUBICIN, ALTGIST, AGADIR, AMG706, AMGEN 20060324, ANGIO-NEXT, ANGIOTAX, ANGIOTAX-PLUS, ANNOUNCE 1, ARO-012 CRENOGIST, ASCEND10, ATEZOGIST, BAY734506, BET115521, BFR14, BKM120, BLU-285-1101, BLU-285-1303 , BO20924, BP27772, BP29428, BROSTALLICINE, CA017-003, CA209-848, CABOGIST, CABONE, CAIRE, CAMN107, CGM097, CHDM201X2103C, CHONDROG, CHONRAD, CISTEM, COMBINAIR 3, CONGRATS, CRAD001C2206, CRAD001X2109, CREATE, CSTI571X2103, CYCLIGIST, DCC2618-03-002 : INTRIGUE, DCC2618-23-001 : INTRIGUE , DESMOPAZ, DOVIGIST, E7389-G000-213, E7438-G000-101, EFC 10145, EISAI E7389, EORTC-1202, EORTC-1403-REECUR, EORTC-1447-STBSG, EORTC-1506-STBSG-ANITA, EORTC-62005, EORTC-62012, EORTC-62022-IRESSA , EORTC-62024, EORTC-62043, EORTC-62052, EORTC-62061-STBSG, EORTC 62113-55115 HGUS, EORTC-62953, EORTC-62972, EORTC-90061-BI2536, EORTC STI571, EREMISS, ESTIM-LBH, ET-743, ETC-002-07, EURO-EWING, EURO-EWING 2012, EUROSARC, EZH-102 (EPIZYME), EZH-202, EZH-501, Far-RMS, FDH-609, FIVE PRIME, GCS O12, GEIS-32, GIGIST-LB, GIMATECAN, GO29664, GP28153, H6Q-MC-JCAY, I3G-MC-JGCB, I5B-MC-JGDJ : ANNOUNCE, I5B-MC-JGDL : ANNOUNCE 2, I5B-MC-JGDM, I6F-MC-JJCD, IDRX-42-001, IMCLONE, IMADGIST, INTRIGUE DCC 2618 03002, INVICTUS, ISI-JX, IROFULVEN, KCP-330-020 SEAL, KIDES-203, LEE011, LENVAGIST, LMS02, LMS03, LMS04, LOXO-TRAK, MDR-S9788, MEGAMOST, MEKi, MEN 10755, METRO-PD1, METROMAJX, METZOLIMOS, MK 7339, MK 7902-013, MK 8669-DALORI, ML43313-COTESARC, MMT 95, MO29518 basket, MOLMED, MORAb-004, MOST, MOST Plus, MULTISARC C16-40, NAVE-CYCLO, NB003-01, NBTXR3-301, NEOSARCOMICS, NP27872, NP28021, NVL-655-01, OP690, OS 2006, OSII-TTP, PAL-ANGI3, PALETTE, PALSAR, PALSAR II, PAZOGIST, PEAK, PEMBROSARC, PICASSO, PICASSO 3, PIPER, PLX108-10, PO4720, PRESOV, PVNS, RADIOSARP, RAR-IMMUNE, REGISTRI, REGO-SARC, REGOBONE, REGOMAIN, REGOMUNE, REGOSTA, RMS 2005, RT-IMMUNE, RT-SUTENT, SAKK 56/07, SAR-1001, SAR04/0205, SARC011 R1507, SARC021-THRESHOLD, SARCOME 13, SCH717454, SEAL-KCP-330-020 , SHIVA, STARTRK2, STARTRK GO40782, STI 571, STING GSK 208850, SU011248, SUCCEED, SYNFRIZZ, TAIL, TAPISTRY BO41932 , TAPPAS, TARMIC, TAXOGEM, T-DIS, TH-CR-406, TH302, TRAMUNE, TRAST, TRUST, TSAR, VEBASKET, VEG105430 , VINFLUNINE IN104, VIT-0910, XGEVA AMGEN |
ID : 1484
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Neo-adjuvant, Adjuvant, Palliative, Maintenance |
ID : 1030
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Yes: the patient had progressive disease at the date of last-follow up; no: no progressive disease observed at the date of last follow-up
|
Possible values :
Yes, No, Not available |
ID : 1012
Type : Free value Content : DATE Mandatory : No Multiple values : No Unique : No |
Description : Date of tumour progression under chemotharapy
|
|
ID : 1011
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : Best response observed during chemotherapy: complete response; partial response; stable disease or progressive disease
|
Possible values :
Complete response, Partial response, Stable disease, Progressive disease, Not evaluable |
ID : 1194
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fos B , Fox2B, FoxL2, Fli1, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1 |
ID : 1196
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Pancytokeratin AE1/AE3, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1 |
ID : 1195
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, EBV (LMP), E-Cadherin, EGFr, EMA, HHF35, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1 |
ID : 1197
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NRAS (Q61R), NSE, NR3C4, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1 |
ID : 1198
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM4, MDM2, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1 |
ID : 137
Type : Free value Content : PERCENTAGE Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 138
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 81
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Yes, No |
ID : 1204
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1208
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 84
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
No, Yes |
ID : 187
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1 |
ID : 186
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-ETAF1, EWSR1-PATZ1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1 |
ID : 188
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1 |
ID : 88
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description : FISH performed
|
Possible values :
No, Yes |
ID : 1082
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), JAZF1 (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, HMGA2, RB1, FN1, APOD, FGFR1, PRKCD |
ID : 1081
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), JAZF1 (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-ERG, EWSR1-FLI1, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, HMGA2, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, FN1, APOD, FGFR1, PRKCD |
ID : 1083
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
CIC (BA), COL1A1- PDGFB (fusion), DDIT3 (BA), ETV6 (BA), EWSR1 (BA), FOXOA1 (BA), FUS (BA), PDGFB (BA), PHF1 (BA), JAZF1 (BA), SSI8 (BA), TFE3 (BA), USP6 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CAMTA1 (BA), CKN2A (P16), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, HMGA2, FN1, APOD, FGFR1, PRKCD |
ID : 1200
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
APC, BRAF, CTNNB1, GNAS, H3F3A, H3F3B, INI1, KIT, MYOD1, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD, SMARCA4, SMARCB1, TP53, Other |
ID : 1238
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 101
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, Non amplifiable DNA |
ID : 100
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1202
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
V600E, Other, No mutation, Non amplifiable DNA |
ID : 1203
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 98
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
41A mutation, 45F mutation, 45P mutation, Other mutation, No mutation, Non amplifiable DNA |
ID : 97
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1209
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1210
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1211
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1212
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 95
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, Non amplifiable DNA |
ID : 94
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1213
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
Exon9, Exon11, Exon13, Exon17, Other exon, No mutation, No amplifiable DNA |
ID : 1214
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1233
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1234
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1243
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1242
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1245
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1244
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1247
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1246
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1215
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1216
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1217
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1218
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1219
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
Exon12, Exon14, Exon18, Other exon, No mutation, No amplifiable DNA |
ID : 1220
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1239
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1240
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1249
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1248
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1250
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1251
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 1221
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1222
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1223
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1224
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1225
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1226
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1227
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1228
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1229
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1230
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 1231
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, No amplifiable DNA |
ID : 1232
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
DHPLC, Sequencing, Both, Other |
ID : 161
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Mutation, No mutation, Non amplifiable DNA |
ID : 160
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Sequencing, Functional assay, Both, Other |
ID : 162
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 163
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 164
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 165
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 83
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Yes, No |
ID : 1201
Type : Constrained Content : TEXT Mandatory : No Multiple values : Yes Unique : No |
Description :
|
Possible values :
CDK4, CMYC, MDM2, Other |
ID : 1237
Type : Free value Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
|
ID : 107
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Negative, Positive, Non interpretable |
ID : 106
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
FISH, Q-PCR, Array-CGH, Other |
ID : 1235
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Negative, Positive, Non interpretable |
ID : 1236
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
FISH, Q-PCR, Array-CGH, Other |
ID : 104
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Negative, Positive, Non interpretable |
ID : 103
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
FISH, Q-PCR, Array-CGH, Other |
ID : 166
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
Yes, No |
ID : 167
Type : Constrained Content : TEXT Mandatory : No Multiple values : No Unique : No |
Description :
|
Possible values :
WT, Mut |
Version 5.4.5 |